An ingredient in erectile dysfunction medication may help treat oesophageal cancer, a study has found.

Southampton researchers found the PDE5 inhibitors in the medication helped penetrate the barrier of cells around tumours, enabling chemotherapy drugs to reach cancer cells.

One in 10 patients currently survives the disease, which is found anywhere in the gullet, for ten years or more.
The study was funded by Cancer Research UK. The next stage is a clinical trial.
Source : BBC